The emerging role of GPR50 receptor in brain

Biomedicine and Pharmacotherapy

Volumn 78, Issue , 2016, Pages 121-128

  Khan, Muhammad zahid ^a   He, Ling ^a   zhuang, Xuxu ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Glucocorticoid receptor signaling; GPR50 receptor; Hypothalamus pituitary adrenal axis; Neural progenitor cells; Neurite outgrowth; Torpor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 50; GLUCOCORTICOID RECEPTOR; LEPTIN; MELATONIN RECEPTOR; UNCLASSIFIED DRUG; GPR50 PROTEIN, HUMAN; NERVE PROTEIN;

BRAIN; CHEMICAL STRUCTURE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL DISEASE; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEURAL STEM CELL; NEUROBIOLOGY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THERMOGENESIS; TORPOR; ANIMAL; CHEMISTRY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; HUMANS; MENTAL DISORDERS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION;

EID: 84958675811     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.01.003     Document Type: Review

References (94)

1. Lundstrom K. Latest development in drug discovery on G protein-coupled receptors. Curr. Protein. Pept. Sci. 2006, 7:465-470.
2. Violin J.D., Crombie A.L., Soergel D.G., Lark M.W. Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol. Sci. 2014, 35:308-316.
3. Li D.Y., Smith D.G., Hardeland R., Yang M.Y., Xu H.L., Zhang L., Yin H.D., Zhu Q. Melatonin receptor genes in vertebrates. Int. J. Mol. Sci. 2013, 14:11208-11223.
4. Reppert S.M., Weaver D.R., Ebisawa T., Mahle C.D., Kolakowski L.F. Cloning of a melatonin-related receptor from human pituitary. FEBS Lett. 1996, 386:219-224.
5. Hamouda H.O., Chen P., Levoye A., Sözer-Topçular N., Daulat A.M., Guillaume J.L., Ravid R., Savaskan E., Ferry G., Boutin J.A. Detection of the human GPR50 orphan seven transmembrane protein by polyclonal antibodies mapping different epitopes. J. Pineal Res. 2007, 43:10-15.
6. Grünewald E., Kinnell H.L., Porteous D.J., Thomson P.A. GPR50 interacts with neuronal NOGO-and affects neurite outgrowth. Mol. Cell. Neurosci. 2009, 42:363-371.
7. Thomson P.A., Wray N.R., Thomson A.M., Dunbar D.R., Grassie M.A., Condie A., Walker M.T., Smith D.J., Pulford D.J., Muir W., Blackwood D.H., Porteous D.J. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Mol. Psychiatry 2005, 10:470-478.
8. Alaerts M., Venken T., Lenaerts A.S., De Zutter S., Norrback K.F., Adolfsson R., Del-Favero J. Lack of association of an insertion/deletion polymorphism in the G protein-coupled receptor 50 with bipolar disorder in a Northern Swedish population. Psychiatr. Genet. 2006, 16:235-236.
9. Bhattacharyya S., Luan J., Challis B., Keogh J., Montague C., Brennand J., Morten J., Lowenbeim S., Jenkins S., Farooqi I.S., Wareham N.J., O'Rahilly S. Sequence variants in the melatonin-related receptor gene (GPR50) associate with circulating triglyceride and HDL levels. J. Lipid Res. 2006, 47:761-766.
10. Li D.Y., Smith D.G., Hardeland R., Yang M.Y., Xu H.L., Zhang L., Yin H.D., Zhu Q. Melatonin receptor genes in vertebrates. Int. J. Mol. Sci. 2013, 14:11208-11223.
11. Levoye A., Dam J., Ayoub M.A., Guillaume J.L., Couturier C., Delagrange P., Jockers R. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J. 2006, 25:3012-3023.
12. Jockers R., Maurice P., Boutin J.A., Delagrange P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?. Br. J. Pharmacol. 2008, 154:1182-1195.
13. Thomson P., Wray N., Thomson A., Dunbar D., Grassie M., Condie A., Walker M., Smith D., Pulford D., Muir W. Sex-specific association between bipolar affective disorder in women and GPR50: an X-linked orphan G protein-coupled receptor. Mol. Psychiatry 2004, 10:470-478.
14. Delavest M., Even C., Benjemaa N., Poirier M.F., Jockers R., Krebs M.O. Association of the intronic rs2072621 polymorphism of the X-linked GPR50 gene with affective disorder with seasonal pattern. Eur. Psychiatry 2012, 27:369-371.
15. Levoye A., Dam J., Ayoub M.A., Guillaume J.L., Jockers R. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep. 2006, 7:1094-1098.
16. Levoye A., Jockers R. Alternative drug discovery approaches for orphan GPCRs. Drug Discovery Today 2007, 13:52-58.
17. Ivanova E.A., Bechtold D.A., Dupré S.M., Brennand J., Barrett P., Luckman S.M., Loudon A.S. Altered metabolism in the melatonin-related receptor (GPR50) knockout mouse. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E176-E182.
18. Vassilatis D.K., Hohmann J.G., Zeng H., Li F., Ranchalis J.E., Mortrud M.T., Brown A., Rodriguez S.S., Weller J.R., Wright A.C., Bergmann J.E., Gaitanaris G.A. The G protein-coupled receptor repertoires of human and mouse. Proc. Natl Acad. Sci. U. S. A. 2003, 100:4903-4908.
19. Sidibe A., Mullier A., Chen P., Baroncini M., Boutin J.A., Delagrange P., Prevot V., Jockers R. Expression of the orphan GPR50 protein in rodent and human dorsomedial hypothalamus, tanycytes and median eminence. J. Pineal Res. 2010, 48:263-269.
20. Batailler M., Mullier A., Sidibe A., Delagrange P., Prévot V., Jockers R., Migaud M. Neuroanatomical distribution of the orphan GPR50 receptor in adult sheep and rodent brains. J. Neuroendocrinol. 2012, 24:798-808.
21. Grünewald E., Tew K.D., Porteous D.J., Thomson P.A. Developmental expression of orphan G protein-coupled receptor 50 in the mouse brain. ACS Chem. Neurosci. 2012, 3:459-472.
22. Pariante C.M. Depression: stress and the adrenal axis. J. Neuroendocrinol. 2003, 15:811-812.
23. Reppert S.M., Perlow M.J., Ungerleider L.G., Mishkin M., Tamarkin L., Orloff D.G., Hoffman H.J., Klein D.C. Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in therhesus monkey. J. Neurosci. 1981, 1:1414-1425.
24. Drew J.E., Barrett P., Mercer J.G., Moar K.M., Canet E., Delagrange P., Morgan P.J. Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J. Neuroendocrinol. 2001, 13:453-458.
25. Li J., Hand L.E., Meng Q.J., Loudon A.S., Bechtold D.A. GPR50 interacts with TIP60 to modulate glucocorticoid receptor signalling. PLoS One 2011, 6.
26. Kamine J., Elangovan B., Subramanian T., Coleman D., Chinnadurai G. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-Tat transactivator. Virology 1996, 216:357-366.
27. Yamamoto T., Horikoshi M. Novel substrate specificity of the histone acetyltransferase activity of HIV-1-Tat interactive protein Tip60. J. Biol. Chem. 1997, 272:30595-30598.
28. Sapountzi V., Logan I.R., Robson C.N. Cellular functions of TIP60. Int. J. Biochem. Cell Biol. 2006, 38:1496-1509.
29. McAllister D., Merlo X., Lough J. Characterization and expression of the mouse tat interactive protein 60 kD (TIP60) gene. Gene 2002, 289:169-176.
30. Gaughan L., Brady M.E., Cook S., Neal D.E., Robson C.N. Tip60 is a coactivator specific for class I nuclear hormone receptors. J. Biol. Chem. 2001, 276:46841-46848.
31. Brady M.E., Ozanne D.M., Gaughan L., Waite I., Cook S., Neal D.E., Robson C.N. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 1999, 274:17599-17604.
32. van Beekum O., Brenkman A.B., Grøntved L., Hamers N., van den Broek N.J., Berger R., Mandrup S., Kalkhoven E. The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-activated receptor gamma. Endocrinology 2008, 149:1840-1849.
33. WHO The World Health Report ental Health: New Understanding, New Hope 2001, 22-29. World Health Organisation.
34. Kinney D.K., Matthysse S. Genetic transmission of schizophrenia. Annu. Rev. Med. 1978, 29:459-473.
35. Macintyre D.J., McGhee K.A., Maclean A.W., Afzal M., Briffa K., Henry B., Thomson P.A., Muir W.J., Blackwood D.H. Association of GPR50, an X-linked orphan G protein-coupled receptor, and affective disorder in an independent sample of the Scottish population. Neurosci. Lett. 2010, 169-173.
36. Ryan J., Carrière I., Ritchie K., Ancelin M.L. Involvement of GPR50 polymorphisms in depression: independent replication in a prospective elderly cohort. Brain Behav. 2015, 5(3):e00313. 10.1002/brb3.313.
37. Heldmaier G., Ortmann S., Elvert R. Natural hypometabolism during hibernation and daily torpor in mammals. Respir. Physiol. Neurobiol. 2004, 141:317-329.
38. Geiser F. Metabolic rate and body temperature reduction during hibernation and daily torpor. Annu. Rev. Physiol. 2004, 66:239-274.
39. Hainsworth F.R., Wolf L.L. Regulation of oxygen consumption and body temperature during torpor in a hummingbird, Eulampis jugularis. Science 1970, 168:368-369.
40. Geiser F. Hibernation and daily torpor in marsupials-review. Australian J. Zool. 1994, 42:1-16.
41. Bartels W., Law B.S., Geiser F. Daily torpor and energetics in a tropical mammal, the northern blossom-bat Macroglossus minimus (Megachiroptera). J. Comp. Physiol. B 1998, 168(3):233-239.
42. Melvin R.G., Andrews M.T. Torpor induction in mammals: recent discoveries fueling new ideas. Trends Endocrinol. Metab. 2009, 20:490-498.
43. Webb G.P., Jagot S.A., Jakobson M.E. Fasting-induced torpor in Mus musculus and its implications in the use of murine models for human obesity studies. Comp. Biochem. Physiol. Comp. Physiol. 1982, 72:211-219.
44. Gavrilova O., Leon L.R., Marcus-Samuels B., Mason M.M., Castle A.L., Refetoff S., Vinson C., Reitman M.L. Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14623-14628.
45. Freeman D.A., Lewis D.A., Kauffman A.S., Blum R.M., Dark J. Reduced leptin concentrations are permissive for display of torpor in Siberian hamsters. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R97-R103.
46. Gluck E.F., Stephens N., Swoap S.J. Peripheral ghrelin deepens torpor bouts in mice through the arcuate nucleus neuropeptide Y signaling pathway. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1303-R1309.
47. Brennan A., Mantzoros C. Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nat. Clin. Pract. Endocrinol. Metab. 2006, 2:318-327.
48. Baicy K., London E.D., Monterosso J., Wong M.L., Delibasi T., Sharma A., Licinio J. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18276-18279.
49. Wardlaw S. Clinical review 127: Obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J. Clin. Endocrinol. Metab. 2001, 86:1442-1446.
50. Taylor T., Wondisford F.E., Blaine T., Weintraub B.D. The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion. Endocrinology 1990, 126:317-324.
51. Lechan R.M., Fekete C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog. Brain Res. 2006, 153:209-235.
52. Bechtold D.A., Sidibe A., Saer B.R., Li J., Hand L.E., Ivanova E.A., Darras V.M., Dam J., Jockers R., Luckman S.M., Loudon A.S. A role for the melatonin related receptor GPR50 in leptin signaling adaptive thermogenesis, and torpor. Curr. Biol. 2012, 10:70-77.
53. Nedergaard J., Cannon B. Brown adipose tissue: receptors and recruitment. Temperature regulation. Adv. Pharmacol. Sci. 1994, 345-350.
54. J. Nedergaard, B. Cannon Brown, Adipose Tissue: A Seasonal Tissue in Mammals Including Humans? Living in a Seasonal World, (2012) 447-458.
55. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
56. GrandPré T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 2000, 403:439-444.
57. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature 2000.
58. Huber A.B., Weinmann O., Brösamle C., Oertle T., Schwab M.E. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 2002, 22:3553-3567.
59. Hunt D., Coffin R.S., Prinjha R.K., Campbell G., Anderson P.N. Nogo-expression in the intact and injured nervous system. Mol. Cell Neurosci. 2003, 24:1083-1102.
60. Tozaki H., Kawasaki T., Takagi Y., Hirata T. Expression of Nogo protein by growing axons in the developing nervous system. Brain Res. Mol. Brain Res. 2002, 104:111-119.
61. He Z., Koprivica V. The Nogo signaling pathway for regeneration block. Annu. Rev. Neurosci. 2004, 341-368.
62. Filbin M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 2003, 4:703-713.
63. Mingorance A., Fontana X., Solé M., Burgaya F., Ureña J.M., Teng F.Y., Tang B.L., Hunt D., Anderson P.N., Bethea J.R., Schwab M.E., Soriano E., del Río J.A. Regulation of Nogo and Nogo receptor during the development of the entorhino hippocampal pathway and after adult hippocampal lesions. Mol. Cell. Neurosci. 2004, 26:34-49.
64. 2+ signaling and NFAT activation. FASEB J. 2009, 23:183-193.
65. Lee C.W., Rivera R., Gardell S., Dubin A.E., Chun J. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J. Biol. Chem. 2006, 281:23589-23597.
66. Jaffe A.B., Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005, 21:247-269.
67. Kiss C., Li J., Szeles A., Gizatullin R.Z., Kashuba V.I., Lushnikova T., Protopopov A.I., Kelve M., Kiss H., Kholodnyuk I.D., Imreh S., Klein G., Zabarovsky E.R. Assignment of the ARHA and GPX1 genes to human chromosome bands 3p21: 3 by in situ hybridization and with somatic cell hybrids. Cytogenet. Cell Genet. 1997, 79:228-230.
68. Lehmann M., Fournier A., Selles-Navarro I., Dergham P., Sebok A., Leclerc N., Tigyi G., McKerracher L. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 1999, 19:7537-7547.
69. Fujita Y., Yamashita T. Axon growth inhibition by RhoA/ROCK in the central nervous system. Front. Neurosci. 2014, 8:338.
70. Mueller B.K., Mack H., Teusch N. Rho kinase: a promising drug target for neurological disorders. Nat. Rev. Drug Discov. 2005, 4:387-398.
71. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-627.
72. Gratzner H.G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982, 218:474-475.
73. Kee N., Sivalingam S., Boonstra R., Wojtowicz J.M. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 2002, 115:97-105.
74. Eriksson P.S., Perfilieva E., Björk-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 1998, 4:1313-1317.
75. Temple S. The development of neural stem cells. Nature 2001, 414:112-117.
76. Taupin P. Adult neurogenesis, neural stem cells and Alzheimer's disease: developments, limitations, problems and promises. Curr. Alzheimer Res. 2009, 6:461-470.
77. Ma Q.H., Futagawa T., Yang W.L., Jiang X.D., Zeng L., Takeda Y., Xu R.X., Bagnard D., Schachner M., Furley A.J., Karagogeos D., Watanabe K., Dawe G.S., Xiao Z.C. A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis. Nat. Cell Biol. 2008, 10:283-U229.
78. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., Lesch K.P. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol. Psychiatry 2006, 11:514-522.
79. Amiri A., Cho W., Zhou J., Birnbaum S.G., Sinton C.M., McKay R.M., Parada L.F. Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. J. Neurosci. 2012, 32:5880-5890.
80. Peñagarikano O., Abrahams B.S., Herman E.I., Winden K.D., Gdalyahu A., Dong H., Sonnenblick L.I., Gruver R., Almajano J., Bragin A., Golshani P., Trachtenberg J.T., Peles E., Geschwind D.H. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011, 147:235-246.
81. Chen H.M., et al. Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients. Transl. Psychiatry 2014, 4:e375.
82. Eisch A.J., Petrik D. Depression and hippocampal neurogenesis: a road to remission?. Science 2012, 338:72-75.
83. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
84. Lucassen P.J., Stumpel M.W., Wang Q., Aronica E. Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients. Neuropharmacology 2010, 58:940-949.
85. Macintyre D.J., McGhee K.A., Maclean A.W., Afzal M., Briffa K., Henry B., Thomson P.A., Muir W.J., Blackwood D.H. Association of GPR50 an X-linked orphan G protein-coupled receptor, and affective disorder in an independent sample of the Scottish population. Neurosci. Lett. 2010, 475:169-173.
86. Gogtay N., Ordonez A., Herman D.H., Hayashi K.M., Greenstein D., Vaituzis C., Lenane M., Clasen L., Sharp W., Giedd J.N., Jung D., 3rd Nugent T.F., Toga A.W., Leibenluft E., Thompson P.M., Rapoport J.L. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J. Child Psychol. Psychiatry 2007, 48:852-862.
87. Ma Y.X., Wu Z.Q., Feng Y.J., Xiao Z.C., Qin X.L., Ma Q.H. G protein coupled receptor 50 promotes self-renewal and neuronal differentiation of embryonic neural progenitor cells through regulation of notch and wnt/β-catenin signalings. Biochem. Biophys. Res. Commun 2015, 458(4):836-842.
88. Kaldis P., Pagano M. Wnt Signaling in Mitosis. Dev. Cell 2009, 17(6):749-750.
89. Hirabayashi Y., Itoh Y., Tabata H., Nakajima K., Akiyama T., Masuyama N., Gotoh Y. The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development 2004, 131:2791-2801.
90. Megason S.G., McMahon A.P. A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development 2002, 129:2087-2098.
91. Chenn A., Walsh C.A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002, 297:365-369.
92. Kageyama R., Ohtsuka T., Shimojo H., Imayoshi I. Dynamic regulation of Notch signaling in neural progenitor cells. Curr. Opin. Cell. Biol. 2009, 21:733-740.
93. Gil V., Nicolas O., Mingorance A., Urena J.M., Tang B.L., Hirata T., Saez-Valero J., Ferrer I., Soriano E., del Rio J.A. Nogo-expression in the human hippocampus in normal aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65:433-444.
94. Novak G., Kim D., Seeman P., Tallerico T. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res. 2002, 107:183-189.